Global Penile Implants Market 2016-2020
About the Penile Implants Market
ED is typically caused by various conditions including congenital anomalies, iatrogenesis, vascular conditions (including cardiovascular disease, diabetes, and high blood pressure), Peyronie's disease, penile or pelvic trauma, and complications in treating prostate cancer. Penile implants, or penile prosthesis, are a method of treating ED. These devices are implanted in the corpora cavernosa of the penis through a surgical procedure. Penile implants are considered to be the most effective treatment for ED. These implants are generally considered when less intrusive therapeutic medicines, like oral pharmaceuticals (PDE5 inhibitors: Viagra, Levitra, Cialis), penile infusions, or vacuum erection devices are unsuccessful, give an unsatisfactory result, or are contraindicated.
The penile implants currently offered in the market are categorized into semi-rigid/malleable (bendable) rod penile implants and inflatable penile implants. A penile implant helps enhance a man's psychological and emotional well-being as well as restore sexual satisfaction.
Technavio’s analysts forecast the global penile implants market to grow at a CAGR of 1.58% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global penile implants market for 2016-2020. The market size was calculated from the revenue generated by the sales of various penile implant devices to treat ED. The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Penile Implants Market 2016-2020
Technavio recognizes the following companies as the key players in the Global Penile Implants Market: American Medical Systems, Zephyr Surgical Implants (ZSI), Promedon, and Coloplast.
Other Prominent Vendors in the market are: Shah, HR Penile Prosthesis, Silimed Malleable Implant, Jonas (ESKA) Prosthesis, Virilis I Implant and Virilis II Implant, and Apollo implant.
Commenting on the report, an analyst from Technavio’s team said: “There are many technologies being developed to treat ED. These include external penile support devices, low intensity extracorporeal shockwave, penile vibrators, nanotechnology, tissue engineering, and endovascular technology. These technologies are expected to revolutionize the treatment methods for ED. In addition, large investments are being made in stem cell therapy for ED. Studies on the effects of stem cell therapy showed results of improved endothelium, muscle, and nerve in the erectile tissue.”
According to the report, a key trend that will fuel the market in future is the investments made by large pharmaceutical companies in R&D of new technologies related to external penile support devices, nanotechnology, low intensity extracorporeal shockwave, tissue engineering, and endovascular technology.
Further, the report states that the availability of various other treatments, such as oral PDE5 inhibitors, intracavernosal injections, intraurethral medications, and cost factors are some of the critical challenges that have resulted in the slow growth of the market. These alternative treatments are more advanced and easily available around the world, making them a preferable option over penile implants.
American Medical Systems, Zephyr Surgical Implants (ZSI), Promedon, Coloplast, Shah, HR Penile Prosthesis, Silimed Malleable Implant, Jonas (ESKA) Prosthesis, Virilis I Implant and Virilis II Implant, Apollo implant.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook